Published in TB and Outbreaks Week, October 8th, 2002
The FDA has advised the company that a target action date is expected within 6 months.
The filing includes data from a trial with more than 24,000 patients, which is the largest single comparative antibiotic trial ever conducted.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.